Fox Run Management, L.L.C. Dr Reddys Laboratories LTD Transaction History
Fox Run Management, L.L.C.
- $553 Million
- Q2 2025
A detailed history of Fox Run Management, L.L.C. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 35,656 shares of RDY stock, worth $515,942. This represents 0.1% of its overall portfolio holdings.
Number of Shares
35,656
Previous 10,817
229.63%
Holding current value
$515,942
Previous $142,000
276.76%
% of portfolio
0.1%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding RDY
# of Institutions
259Shares Held
93.2MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$189 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$144 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$130 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$92 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$78.1 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.4B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...